Cardiome Pharma (CRME)

Add to Watchlists
Create an Alert
1.41 +0.00  +0.00% NASDAQ Feb 23, 15:19 Delayed 2m USD

Cardiome Pharma Total Liabilities (Quarterly):

49.58M for Sept. 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Cardiome Pharma Total Liabilities (Quarterly) Chart

Export Data
Save Image
Print Image

Cardiome Pharma Historical Total Liabilities (Quarterly) Data

View and export this data going back to 1997. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2017 49.58M
June 30, 2017 40.36M
March 31, 2017 31.70M
Dec. 31, 2016 33.03M
Sept. 30, 2016 32.53M
June 30, 2016 44.48M
March 31, 2016 24.61M
Dec. 31, 2015 28.29M
Sept. 30, 2015 29.33M
June 30, 2015 30.96M
March 31, 2015 28.59M
Dec. 31, 2014 32.98M
Sept. 30, 2014 29.84M
June 30, 2014 18.41M
March 31, 2014 19.33M
Dec. 31, 2013 24.69M
Sept. 30, 2013 3.346M
June 30, 2013 1.763M
March 31, 2013 2.021M
Dec. 31, 2012 36.93M
Sept. 30, 2012 57.24M
June 30, 2012 52.89M
March 31, 2012 52.95M
Dec. 31, 2011 28.75M
Sept. 30, 2011 28.74M
   
June 30, 2011 29.61M
March 31, 2011 30.63M
Dec. 31, 2010 31.41M
Sept. 30, 2010 31.24M
June 30, 2010 30.16M
March 31, 2010 43.17M
Dec. 31, 2009 43.72M
Sept. 30, 2009 68.84M
June 30, 2009 59.07M
March 31, 2009 9.117M
Dec. 31, 2008 10.36M
Sept. 30, 2008 12.99M
June 30, 2008 16.32M
March 31, 2008 20.97M
Dec. 31, 2007 18.74M
Sept. 30, 2007 13.22M
June 30, 2007 10.82M
March 31, 2007 10.52M
Dec. 31, 2006 13.50M
Sept. 30, 2006 11.86M
June 30, 2006 11.62M
March 31, 2006 11.08M
Dec. 31, 2005 12.56M
Sept. 30, 2005 9.614M
June 30, 2005 15.65M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Advertisement

CRME Total Liabilities (Quarterly) Benchmarks

Benchmarks
Aralez Pharmaceuticals 412.15M
Sunshine Biopharma 0.6099M
Intelgenx Technologies 10.38M

CRME Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 1.763M Jun 2013
Maximum 49.58M Sep 2017
Average 26.62M

CRME Total Liabilities (Quarterly) Excel Add-In Codes

  • Metric Code: liabilities
  • Latest data point: =YCP("CRME", "liabilities")
  • Last 5 data points: =YCS("CRME", "liabilities", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.